Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Psoriasiform eruption"'
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 51, Iss 7, Pp 417-425 (2023)
Tyrosine kinase inhibitor imatinib is a standard agent for treatment of gastrointestinal stromal tumors (GIST). Treatment courses are quite long and are usually well tolerated. However, skin rash can occur on treatment, with a prevalence of 7 to 88.9
Externí odkaz:
https://doaj.org/article/8d1b6558ba104520b66f3231de0e140c
Publikováno v:
Liaquat National Journal of Primary Care, Vol 4, Iss 2, Pp 144-146 (2022)
The term infantile seborrhoeic dermatitis is used to describe as apparently particularly eczematous or psoriasiform eruption seen in infants, having a fondness for the scalp and flexures, and can be compared with atopic dermatitis. This is a very co
Externí odkaz:
https://doaj.org/article/d60a679fbccb457f98db6669e2cf1010
Publikováno v:
Case Reports in Dermatology, Vol 8, Iss 3, Pp 369-373 (2016)
Propranolol, a nonselective blocker of β-adrenergic receptors, has become the first-line treatment for complicated infantile hemangiomas. Therefore, its use in the pediatric population has expanded in recent years. In adults, β-blockers have been r
Externí odkaz:
https://doaj.org/article/3f2c52fcae4e465c93a6ded3b4a7ffb2
Publikováno v:
Expert opinion on biological therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772d29220a62f656c91b04a0b302d6c8
https://pubmed.ncbi.nlm.nih.gov/36445319
https://pubmed.ncbi.nlm.nih.gov/36445319
Autor:
Ming-Chun Hsu, Chih-Chiang Chen
Publikováno v:
Dermatologica Sinica, Vol 34, Iss 3, Pp 148-150 (2016)
Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis. While adverse skin reactions occur in 90% of patients treated with angiogenesis inhibitors, only a few cases of psoriasiform eruption associated with sorafeni
Externí odkaz:
https://doaj.org/article/5a40e4db1a664494909f0ec0be6cafa4
Publikováno v:
Clinical Toxicology. 57:1125-1127
Dear editor,Teriflunomide is a relatively new oral medication that is introduced as first-line treatment in patients with multiple sclerosis. Teriflunomide inhibits dihydroorotate dehydrogenase (DH...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d731b73c9661878f8f5a63880211b5f
https://doi.org/10.1080/15563650.2019.1581940
https://doi.org/10.1080/15563650.2019.1581940
Autor:
Yumi Ito, Toshiaki Tanabe, Naohisa Ichiki, Miho Sugata, Masanori Kodera, Satoko Hisada, Tomonori Komatsu
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 4, Iss 3, Pp 67-68 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d22dba5ffadfcb0edd7ab51a7293b0
https://doaj.org/article/0531c0795a3e45b0b24ece7c30d0581b
https://doaj.org/article/0531c0795a3e45b0b24ece7c30d0581b
Autor:
Sara Renna, Ambrogio Orlando, Fabio Salvatore Macaluso, Valentina Caputo, Elisabetta Orlando, Maria Rita Bongiorno, Giuseppe Maria Garbo, R. Orlando
Publikováno v:
Alimentary Pharmacology & Therapeutics. 50:342-343
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c8dc9653f31f2ac21571b051477c39
https://doi.org/10.1111/apt.15389
https://doi.org/10.1111/apt.15389
Autor:
Norihito Hida, Emmi Yamada, Taisuke Nakaizumi, Hideyasu Yamada, Hiroaki Satoh, Takashi Matsuda, Nobuyuki Hizawa
Publikováno v:
Allergology International, Vol 69, Iss 3, Pp 478-479 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ee0d1e52dd60a0279641e67cb9542a5
https://tsukuba.repo.nii.ac.jp/records/2002552
https://tsukuba.repo.nii.ac.jp/records/2002552
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 4, Iss 4, Pp 373-375 (2018)
JAAD Case Reports, Vol 4, Iss 4, Pp 373-375 (2018)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f2b77023f0cf1f4e3e9c8b651eaafd
https://doi.org/10.1016/j.jdcr.2017.11.014
https://doi.org/10.1016/j.jdcr.2017.11.014